Tag Page ASCO

Cancer Conference Hype: Real Wins for Patients?

Every year, the ASCO cancer conference drops major headlines about new treatments, but do they actually help patients? Turns out, yes! Drugs like Enhertu, Verzenio, and Trodelvy are now FDA-approved and making a real difference—think longer survival, fewer side effects, and better quality of life for breast and lung cancer patients. Plus, new gene-targeted meds are doubling the time some cancers stay in check. The hype is real: these breakthroughs are changing lives! #CancerResearch #ASCO #CancerTreatment #Health